These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5493170)

  • 1. Semiautomated method for measurement of dopa in plasma.
    Spiegel HE; Tonchen AE
    Clin Chem; 1970 Sep; 16(9):763-5. PubMed ID: 5493170
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in the application of high resolution liquid chromatography to the separation of complex biological mixtures.
    Scott CD; Chilcote DD; Katz S; Pitt WW
    J Chromatogr Sci; 1973 Feb; 11(2):96-100. PubMed ID: 4690243
    [No Abstract]   [Full Text] [Related]  

  • 3. Automated specific fluorimetric methods for epinephrine and norepinephrine assay in a single biological extract.
    Peyrin L; Cottet-Emard JM
    Anal Biochem; 1973 Dec; 56(2):515-31. PubMed ID: 4765642
    [No Abstract]   [Full Text] [Related]  

  • 4. A reliable and simple method for simultaneous determination of DOPA and 3-O-methyldopa in plasma and brain.
    Fahn S; Prasad AL; Delesie R
    Anal Biochem; 1972 Apr; 46(2):557-75. PubMed ID: 4337048
    [No Abstract]   [Full Text] [Related]  

  • 5. A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain.
    Kehr W; Carlsson A; Lindqvist M
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 274(3):273-80. PubMed ID: 4262782
    [No Abstract]   [Full Text] [Related]  

  • 6. A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients.
    Curzon G; Kantamaneni BD; Trigwell J
    Clin Chim Acta; 1972 Mar; 37():335-41. PubMed ID: 5022098
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative determination of D-dopa present in levodopa samples.
    Coppi G; Vidi A; Bonardi G
    J Pharm Sci; 1972 Sep; 61(9):1460-1. PubMed ID: 4626995
    [No Abstract]   [Full Text] [Related]  

  • 8. [Simultaneous spectrofluorimetric analysis of 3,4-dihydroxyphenylalanine (DOPA) and the total amount of the catecholamines adrenalin/noradrenalin in urine].
    Schwedt G
    Clin Chim Acta; 1974 Dec; 57(3):291-6. PubMed ID: 4434648
    [No Abstract]   [Full Text] [Related]  

  • 9. An improved method for the assay of dopa.
    Johnson JC; Gold GJ; Clouet DH
    Anal Biochem; 1973 Jul; 54(1):129-36. PubMed ID: 4737665
    [No Abstract]   [Full Text] [Related]  

  • 10. The subcellular localization of catecholamines in nerve terminals in smooth muscle tissue.
    Austin L; Chubb IW; Livett BG
    J Neurochem; 1967 May; 14(5):473-8. PubMed ID: 6025617
    [No Abstract]   [Full Text] [Related]  

  • 11. A new semiautomated fluorometric method for estimation of small amounts of L-dopa in human urine.
    Blau N; Rosenmund H
    Clin Chim Acta; 1977 Mar; 75(2):213-20. PubMed ID: 14797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamine oxidation and ionization properties indicated from the H+ release, tritium exchange, and spectral changes which occur during ferricyanide oxidation.
    Harrison WH; Whisler WW; Hill BJ
    Biochemistry; 1968 Sep; 7(9):3089-94. PubMed ID: 5684336
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of L-dopa administration of the concentrations of dopa, dopamine and norepinephrine in various rat tissues.
    Romero JA; Lytle LD; Ordonez LA; Wurtman RJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):67-72. PubMed ID: 4686016
    [No Abstract]   [Full Text] [Related]  

  • 14. The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.
    Laverty R; Taylor KM
    Anal Biochem; 1968 Feb; 22(2):269-79. PubMed ID: 4868086
    [No Abstract]   [Full Text] [Related]  

  • 15. A sensitive method for determination of 5-S-cysteinyldopa.
    Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1973; 53(4):248-50. PubMed ID: 4127449
    [No Abstract]   [Full Text] [Related]  

  • 16. A simple radioenzymatic method to measure picogram amounts of DOPA in brain and biological fluids.
    Argiolas A; Gessa GL
    J Neurochem; 1981 Jan; 36(1):290-2. PubMed ID: 6780660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum protein-bound 3,4-dihydroxyphenylalanine and related products of protein oxidation and chronic hemodialysis.
    Sutherland WH; Gieseg SP; Walker RJ; de Jong SA; Firth CA; Scott N
    Ren Fail; 2003 Nov; 25(6):997-1009. PubMed ID: 14669859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopa, 3-O-methyldopa, and metabolites in urine during oral L-3-O-methyldopa therapy.
    Sharpless NS; Tyce GM; Muenter MD; Dinapoli RP
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 1):770-81. PubMed ID: 4426145
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of metabolites of L-dopa--a possible source of error.
    Tyce GM; Sharpless NS; Owen CA
    Biochem Pharmacol; 1972 Sep; 21(17):2409-12. PubMed ID: 4647075
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of the parameters affecting flow gradient analysis of catecholamines, DOPA and DOPAC by ion pair liquid chromatography with electrochemical detection.
    Rossetti ZL; Mercuro G; Rivano CA
    Life Sci; 1983 Dec; 33(24):2387-97. PubMed ID: 6417432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.